+ Direct Access
October 12, 2017

Clinical Trial Commentary

(icTV) Commentary on the LICORN Randomised Clinical Trial

Jean-Paul Mira shares his thoughts on the LICORN trial which sought to answer the question: Does a prophylactic levosimendan infusion reduce the incidence of postoperative low cardiac output syndrome in patients with impaired left ventricular function who are undergoing isolated or combined coronary artery bypass grafting surgery under cardiopulmonary bypass?

Results from this trial were presented at LIVES 2017 in Vienna and have been published in JAMA.

Find the article in JAMA HERE.

Comment on this news